Neuland Laboratories Ltd. (NEULANDLAB): Neuland Laboratories Share Price Hits Fresh 52-Week High
- August 18, 2026
- Posted by: Harsh Piplani
- Category: News
Neuland Laboratories Share Price stood at Rs 23,296.4, down 1.59% today, after touching a fresh 52-week high of Rs 23,850. The company’s market capitalisation was Rs 29,908.4 crore.
Neuland Laboratories Share Price was at Rs 23,296.4 on 18 August 2026, down Rs 376.05 or 1.59% from the previous close of Rs 23,672.45, after the stock touched a fresh 52-week high of Rs 23,850 during the session. With a market capitalisation of Rs 29,908.4 crore and turnover of Rs 3.19 crore, the move has placed the stock firmly in today’s market conversation.
The verified data confirms the price event clearly: Neuland Laboratories Share Price reached a new one-year high intraday even though it later traded below that peak. That matters because fresh 52-week highs often bring a stock into the daily watchlists of traders, long-term market participants and readers tracking Stock Market Today, Share Market Today and market movers across the Healthcare space.
At the same time, the supplied data does not establish a company-specific catalyst behind the move. What it does show is a stock making a fresh yearly high within the session, alongside a valuation profile that stands well above the broader sector median on P/E and below it on P/B, while profitability ratios remain negative. For readers following Neuland Laboratories Stock News, that combination makes the stock notable not just for price action but also for the contrast between momentum attention and fundamental metrics. Univest is therefore looking at both the event and the underlying numbers to explain why the stock is trending and what to monitor next.
Neuland Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 23,296.4 |
| Previous Close | Rs 23,672.45 |
| Today's Change | Rs -376.05 (-1.59%) |
| Day Open | Rs 23,650 |
| Fresh 52-Week High | Rs 23,850 |
| Day Low | Rs 23,272.95 |
| Current Volume | 1,370 |
| Turnover | Rs 3.19 crore |
| Market Capitalisation | Rs 29,908.4 crore |
Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 23,296.4. versus the previous close of Rs 23,672.45, a fall of 1.59%. The stock opened at Rs 23,650, reached Rs 23,850, touched Rs 23,272.95. Reported volume was 1,370.
Neuland Laboratories Share Price Today reflects a session in which the stock made a fresh 52-week peak of Rs 23,850 but then traded lower at Rs 23,296.4, leaving it down 1.59% versus the previous close. The day’s range, opening level and turnover show how the stock drew attention even as it came off the intraday high.
From the opening print of Rs 23,650, Neuland Laboratories Share Price moved up to Rs 23,850, which now stands as the stock’s fresh 52-week high and one-year high. The intraday low was Rs 23,272.95, and the current price of Rs 23,296.4 places the stock near the lower end of the day’s range rather than at the session peak. Against the previous close of Rs 23,672.45, the day change stood at minus Rs 376.05.
That intraday pattern is important for investors reading Neuland Laboratories Share Price Today and Neuland Laboratories Share News. The stock did enough to register a new 52-week peak, but it did not hold the entire early strength into the observed price point. In practical terms, this means the market recognised a higher trading level during the day, yet some profit-booking or intraday supply also appeared before the latest print.
Participation was measured through current volume of 1,370 shares and turnover of Rs 3.19 crore. On a high-priced stock, turnover often gives better context than share count alone, and here it confirms that a meaningful amount of capital changed hands while the stock tested fresh highs. For readers tracking Stocks in News, Top Gainers Today or 52 Week High Stocks, the day’s tape shows a stock that achieved a Technical Breakout on price levels even though the latest quote sat below the intraday top. That makes the next step in analysis less about headline movement alone and more about how valuation and sector context compare with the broader market picture.
Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 29,908.4 crore |
| P/E Ratio | 170.32x |
| P/B Ratio | 0.42x |
| ROE | -2.89% |
| ROCE | -0.26% |
Neuland Laboratories Ltd. was valued at a P/E ratio of 170.32x, a P/B ratio of 0.42x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 170.32x |
| Benchmark Median P/E | 21x |
| Benchmark Average P/E | 49.19x |
| Benchmark P/E Range | 0x to 1,598.54x |
| Company P/B Ratio | 0.42x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 29,908.4 crore |
| Benchmark Median Market Cap | Rs 136.28 crore |
Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.
Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 170.32x, which is above the benchmark median of 21x, a difference of +711.05%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Neuland Laboratories Ltd. (NEULANDLAB) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Neuland Laboratories Ltd. (NEULANDLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,985.15 | 170.32 | 0.42 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,827.67 | 65.02 | 10.29 | 18.65 | 22.17 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,645.37 | 47.53 | 1.82 | -0.78 | 8.31 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,562.17 | 33.62 | 6.93 | -2.6 | 16.92 |
| Fredun Pharmaceuticals Ltd. | FREDUN | 2,559.68 | 54.85 | 8.19 | 11.42 | 13.15 |
Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 170.32x compared with the displayed peer median of 54.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 29,908.4 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Neuland Laboratories
The reasons investors are monitoring Neuland Laboratories Share Price are visible in the verified numbers. The stock has delivered a fresh one-year high, carries a large market capitalisation, and stands out on sector and peer comparisons even without a confirmed company-specific trigger in the supplied data.
- Fresh 52-week high: The stock touched Rs 23,850, establishing a new yearly high during the session.
- Current price action: The latest price was Rs 23,296.4, down 1.59% from Rs 23,672.45, showing intraday volatility after the high.
- Capital scale: Market capitalisation of Rs 29,908.4 crore is far above the sector benchmark average of Rs 468.36 crore.
- Valuation contrast: P/E of 170.32 is above sector median 21 and average 49.19, while P/B of 0.42 is below median 1.9 and average 2.6.
- Profitability context: ROE of -2.89% and ROCE of -0.26% are below the Healthcare benchmark medians of 10.92% and 13.29%.
- Peer positioning: The stock’s market cap is much larger than the supplied peer set, while return ratios trail several peers.
About Neuland Laboratories
Neuland Laboratories Ltd. (NEULANDLAB) is the company at the centre of today’s fresh 52-week high event and is classified within the Healthcare sector in the supplied data. The peer set associated with the stock includes businesses from Pharmaceuticals & Drugs as well as Hospital & Healthcare Services, placing the company within a broad healthcare market context watched closely by investors.
For readers tracking Neuland Laboratories Share Price Today and Neuland Laboratories Latest News, the current focus is less on descriptive company background and more on how the listed stock is behaving within its sector. The company’s market capitalisation of Rs 29,908.4 crore makes it materially larger than the benchmark and peer group figures supplied alongside it. On Univest, investors typically combine that market-position context with price action, valuation ratios and sector benchmarks to understand why a stock has entered the day’s 52-week-high list.
Track Neuland Laboratories Share Price on Univest
Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors using Univest can track Neuland Laboratories Share Price through live market updates, 52-week levels, valuation ratios, market-cap changes and broader stock analysis tools. For a stock that has just entered the fresh 52-week high list, that ongoing tracking becomes important because the daily picture can change quickly between the intraday peak and the closing trend.
Univest also helps users follow Neuland Laboratories Share Price Today in the context of sector benchmarks, peer metrics and ongoing market updates. That includes monitoring how the stock compares with Healthcare valuation medians, how its market capitalisation stacks up against peers, and how its one-year high fits into a broader market narrative. For readers focused on Neuland Laboratories Stock News, the platform offers a structured way to watch the numbers rather than react only to headlines.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current Neuland Laboratories Share Price?
Ans. Neuland Laboratories Share Price was Rs 23,296.4 at the time of this update. The stock was down Rs 376.05, or 1.59%, from the previous close of Rs 23,672.45 after touching a fresh 52-week high intraday.
Did Neuland Laboratories hit a fresh 52-week high today?
Ans. Yes, Neuland Laboratories Share Price touched Rs 23,850 during the session, marking a fresh 52-week high. The stock later traded at Rs 23,296.4, showing that the new one-year high was achieved intraday rather than held fully afterward.
Why is Neuland Laboratories Share Price in focus today?
Ans. The stock is in focus because it reached a fresh 52-week high of Rs 23,850. Even with the latest price at Rs 23,296.4, the one-year-high event has placed it among closely watched market movers today.
What was the intraday range for Neuland Laboratories today?
Ans. Neuland Laboratories traded between Rs 23,272.95 and Rs 23,850 during the session. It opened at Rs 23,650 and later moved below the intraday high, indicating a wide trading band around the fresh yearly peak.
What is the market capitalisation of Neuland Laboratories?
Ans. Neuland Laboratories had a market capitalisation of Rs 29,908.4 crore in the supplied data. That is far above the Healthcare sector benchmark average of Rs 468.36 crore and even above the benchmark maximum of Rs 2,985.15 crore.
How does Neuland Laboratories compare on valuation?
Ans. The stock’s P/E ratio is 170.32, above the Healthcare sector median of 21 and average of 49.19. Its P/B ratio is 0.42, which is below the sector median of 1.9 and average of 2.6.
How do the profitability ratios look for Neuland Laboratories?
Ans. The supplied profitability ratios show ROE at -2.89% and ROCE at -0.26%. Both figures are below the Healthcare sector medians of 10.92% and 13.29%, respectively, based on the 196-company benchmark set.
How does Neuland Laboratories compare with selected peers?
Ans. Neuland Laboratories stands out with a market capitalisation of Rs 29,908.4 crore, much larger than peers such as Beta Drugs at Rs 2,827.67 crore and Fredun Pharmaceuticals at Rs 2,559.68 crore in the supplied comparison set.
What was the turnover and volume in Neuland Laboratories today?
Ans. The supplied session data shows turnover of Rs 3.19 crore and current volume of 1,370 shares. Those figures confirm active trading interest while the stock tested and recorded a fresh 52-week high during the session.
What should investors monitor next in Neuland Laboratories?
Ans. Investors may track whether Neuland Laboratories Share Price holds attention after the fresh 52-week high, while also watching valuation at 170.32 times earnings, P/B at 0.42, and profitability ratios of ROE -2.89% and ROCE -0.26%.
